Artiva Biotherapeutics Inc (ARTV)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.27 +0.23 (+5.69%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.27 unch (unch) 16:20 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,881 | 34,248 | 53,504 | 0 | 0 |
| Marketable Securities | 90,750 | 12,308 | 23,467 | 0 | 0 |
| Receivables | 701 | 1,461 | 1,758 | 0 | 0 |
| TOTAL | $150,565 | $49,749 | $79,821 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 6,857 | 7,315 | 8,096 | N/A | N/A |
| Investments And Advances | 52,966 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 15,208 | 18,848 | 17,197 | 0 | 0 |
| TOTAL | $75,031 | $26,163 | $25,293 | $N/A | $N/A |
| Total Assets | $225,596 | $75,912 | $105,114 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,215 | 823 | 614 | 0 | 0 |
| Accrued Expenses | 8,344 | 6,214 | 8,017 | 0 | 0 |
| TOTAL | $13,292 | $10,827 | $12,227 | $0 | $0 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 11,233 | 256,076 | 254,902 | 0 | 0 |
| TOTAL | $11,308 | $256,182 | $254,902 | $N/A | $N/A |
| Total Liabilities | $24,600 | $267,009 | $267,129 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,289 | 24,287 | N/A | N/A | N/A |
| Common Shares | 3 | N/A | N/A | 0 | 0 |
| Retained earnings | -230,589 | -213,117 | -181,311 | 0 | 0 |
| Other shareholders' equity | 338 | 121 | 308 | 0 | 0 |
| TOTAL | $200,996 | $-191,097 | $-162,015 | $0 | $0 |
| Total Liabilities And Equity | $225,596 | $75,912 | $105,114 | $0 | $0 |